Filing Details
- Accession Number:
- 0001225208-19-004340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 16:29:41
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-04 16:29:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566080 | J. Kevin Ballinger | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp & Pres, Interven Cardio | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-01 | 20,900 | $40.74 | 77,572 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-03-03 | 3,302 | $0.00 | 80,874 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-03 | 1,506 | $40.75 | 79,368 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Deferred Stock Units | Disposition | 2019-03-03 | 3,302 | $0.00 | 3,302 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,909 | 2022-03-03 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.74 to $40.76, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.
Billionaire Hedge Funds
